封面
市场调查报告书
商品编码
1392009

止痛贴市场:按类型、按应用、按技术、按剂型、按处方笺、按患者年龄、按黏合特性、按作用时间、按药物类别、按配销通路、按地区

Pain Patch Market, By Type, By Application, By Technology, By Formulation, By Prescription, By Patient Age, By Adhesive Properties, By Duration of Action, By Drug Class, By Distribution Channel, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 160 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2023年全球止痛贴片市场规模为52.9亿美元,预计到2030年将达到74.5亿美元,2023年至2030年复合年增长率为5%。我是。

报告范围 报告详情
基准年 2022年 2023年市场规模 52.9亿美元
实绩资料 2018-2021 预测期 2023-2030
预测期复合年增长率 5.00% 2030年市场规模预测 74.5亿美元
图 1. 2023 年止痛贴片的全球市场占有率(按地区划分)
止痛贴市场-IMG1

疼痛贴片也称为经皮吸收贴片,是一种黏性贴剂,可直接透过皮肤输送药物以缓解局部疼痛。这些贴片方便、易于使用,并能长时间控制药物释放。由于慢性疼痛疾病的盛行率不断增加以及对替代疼痛管理疗法的需求,疼痛贴片市场在过去十年中经历了显着增长。疼痛贴片也称为经皮治疗系统,可将止痛药透过皮肤输送到血液中,以缓解局部疼痛。与口服药物相比,止痛贴的优点包括更稳定地控制体内药物浓度,避免在肝臟中进行初始代谢,从而降低某些药物的口服生物利用度。此外,新的药物传递技术可以延长贴片中药物的释放时间,从而实现全天候有效的疼痛管理。

市场动态:

疼痛贴片市场主要是由关节炎、下背痛和神经病变疼痛等慢性疼痛疾病的日益普及所推动的。这些情况需要长期的疼痛管理解决方案,而疼痛贴片则提供了一个方便且有效的选择。此外,人们对口服止痛药相关潜在风险(例如成瘾和胃肠道副作用)的认识不断提高,导致人们越来越关注止痛贴等非侵入性药物传递系统。

然而,也存在阻碍市场成长的因素。与传统镇痛药相比,止痛贴的成本较高,而且某些地区这些产品的报销有限,可能会限制市场扩张。此外,疼痛贴片的核准有严格的监管要求,与贴片使用相关的皮肤刺激和过敏反应的风险对市场成长构成了挑战。

儘管有这些挑战,止痛贴片市场仍存在一些成长机会。疼痛贴片中越来越多地采用无线连接和感测器整合等先进技术,为创新和产品差异化铺平了道路。此外,开拓市场尚未开发的潜力以及对个体化疼痛管理解决方案不断增长的需求为市场参与者提供了扩大其影响力并迎合不同消费群体的机会。

本研究的主要特点

  • 本报告对全球止痛贴片市场进行了详细分析,并提供了以2022年为基准年的预测期(2023-2030年)的市场规模和年复合成长率(CAGR%)。
  • 它还揭示了各个细分市场的潜在商机,并为该市场说明了一系列有吸引力的投资提案。
  • 它还提供了有关市场驱动因素、抑制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要考察。
  • 它根据公司亮点、产品系列、主要亮点、绩效和策略等参数,介绍了全球疼痛贴片市场的主要企业。
  • 该报告的见解将帮助行销人员和经营团队就未来的产品发布、类型升级、市场扩张和行销策略负责人资讯的决策。
  • 全球止痛贴市场报告迎合了该行业的各种相关人员,如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
  • 透过用于分析全球止痛贴市场的各种策略矩阵,将促进相关人员的决策。

目录

第1章研究目的与前提

  • 研究目标
  • 假设
  • 简称

第2章市场展望

  • 报告说明
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map(COM)

第3章市场动态、法规及趋势分析

  • 市场动态
    • 对有效缓解疼痛和非侵入性治疗的需求不断增长
    • 皮肤敏感和刺激
    • 个体化疼痛管理的出现
  • 影响分析
  • 主要亮点
  • 监管场景
  • 产品发布/核准
  • PEST分析
  • 波特的分析
  • 併购场景

第4章止痛贴市场-冠状病毒(COVID-19)大流行的影响

  • 新型冠状病毒感染疾病(COVID-19)的流行病学
  • 供需面分析
  • 经济影响

第5章止痛贴市场,依类型,2018-2030

  • 阿片类止痛贴
  • 非鸦片类止痛贴

第6章止痛贴市场,依应用划分,2018-2030

  • 慢性疼痛贴片
  • 急性疼痛贴片

第7章止痛贴片市场(依技术划分),2018-2030 年

  • 常规给药贴片
  • 先进的药物传输贴片

第8章止痛贴市场,按剂型,2018-2030 年

  • 单药贴剂
  • 联合治疗贴片

第9章止痛贴市场,依处方笺,2018-2030

  • 处方止痛贴
  • 非处方 (OTC) 止痛贴片

第10章止痛贴市场,依病患年龄划分,2018-2030 年

  • 成人疼痛贴
  • 儿童用止痛贴

第11章止痛贴片市场(依黏合剂特性),2018-2030 年

  • 防过敏贴片
  • 标准贴片

第12章止痛贴市场,按行动持续时间,2018-2030

  • 短效贴剂
  • 延长发布补丁

第13章止痛贴市场,依药物类别,2018-2030

  • 非类固醇抗发炎药贴剂
  • 局部麻醉贴片
  • 其他的

第14章止痛贴市场,依配销通路划分,2018-2030 年

  • 零售药房
  • 医院和诊所

第15章止痛贴市场,按地区,2018-2030

  • 北美洲
  • 美国
  • 加拿大
  • 欧洲
  • 德国
  • 英国
  • 法国
  • 义大利
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • ASEAN
  • 其他亚太地区
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲
  • 中东
  • GCC
  • 以色列
  • 其他中东地区
  • 非洲
  • 南非
  • 中部非洲
  • 北非

第16章竞争形势

  • Hisamitsu Pharmaceutical Co., Inc.
  • Johnson & Johnson
  • Pfizer Inc.
  • Novartis AG
  • Mylan NV
  • Endo Pharmaceuticals
  • Teikoku Pharma USA, Inc.
  • Acorda Therapeutics
  • Ibsa Institut Biochimique SA
  • Alembic Pharmaceuticals
  • Noven Pharmaceuticals, Inc.
  • Teva Pharmaceuticals
  • Strativa Pharmaceuticals
  • Galen Limited
  • Napp Pharmaceuticals

第17章

  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI6204

The global pain patch market size was valued at US$ 5.29 billion in 2023 and is expected to reach US$ 7.45 billion by 2030, grow at a compound annual growth rate (CAGR) of 5% from 2023 to 2030.

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 5.29 Bn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 5.00% 2030 Value Projection: US$ 7.45 Bn
Figure 1. Global Pain Patch Market Share (%), by Region, 2023
Pain Patch Market - IMG1

Pain patches, also known as transdermal patches, are adhesive patches that deliver medication directly through the skin to provide localized pain relief. These patches are convenient, easy to use, and offer a controlled release of medication over an extended period. The pain patches market has seen significant growth over the past decade driven by the increasing prevalence of chronic pain disorders and the need for alternative pain management therapies. Pain patches, also known as transdermal therapeutic systems, work by delivering pain relieving medications through the skin and into the bloodstream providing localized pain relief. The advantages of pain patches over oral medications include steadier control of drug levels in the body and avoidance of the first-pass liver metabolism which can reduce the oral bioavailability of some drugs. New advanced drug delivery technologies are also enabling prolonged and controlled release of medications from these patches for effective around-the-clock pain management.

Market Dynamics:

The pain patch market is primarily driven by the increasing prevalence of chronic pain conditions, such as arthritis, back pain, and neuropathic pain. These conditions require long-term pain management solutions, and pain patches offer a convenient and effective option. Moreover, the rising awareness about the potential risks associated with oral pain medications, such as addiction and gastrointestinal side effects, is shifting the focus towards non-invasive drug delivery systems like pain patches.

However, the market growth may be hindered by certain factors. The high cost of pain patches compared to traditional pain medications and the limited availability of reimbursement for these products in some regions may restrict market expansion. Additionally, the stringent regulatory requirements for the approval of pain patches and the risk of skin irritation or allergic reactions associated with patch usage pose challenges to market growth.

Despite these challenges, the pain patch market presents several opportunities for growth. The increasing adoption of advanced technologies, such as wireless connectivity and sensor integration in pain patches, opens up avenues for innovation and product differentiation. Furthermore, the untapped potential of emerging markets and the growing demand for personalized pain management solutions provide opportunities for market players to expand their presence and cater to a diverse consumer base.

Key features of the study:

  • This report provides an in-depth analysis of the global pain patch market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global pain patch market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Hisamitsu Pharmaceutical Co., Inc., Johnson & Johnson, Pfizer Inc., Novartis AG, Mylan N.V., Endo Pharmaceuticals, Teikoku Pharma USA, Inc., Acorda Therapeutics, Ibsa Institut Biochimique SA, Alembic Pharmaceuticals, Noven Pharmaceuticals, Inc., Teva Pharmaceuticals, Strativa Pharmaceuticals, Galen Limited, and Napp Pharmaceuticals
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global pain patch market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pain patch market

Detailed Segmentation:

  • By Type
    • Opioid Pain Patches
    • Non-Opioid Pain Patches
  • By Application
    • Chronic Pain Patches
    • Acute Pain Patches
  • By Technology
    • Traditional Drug Delivery Patches
    • Advanced Drug Delivery Patches
  • By Formulation
    • Single Medication Patches
    • Combination Therapy Patches
  • By Prescription
    • Prescription Pain Patches
    • Over-the-Counter (OTC) Pain Patches
  • By Patient Age
    • Adult Pain Patches
    • Pediatric Pain Patches
  • By Adhesive Properties
    • Hypoallergenic Patches
    • Standard Adhesive Patches
  • By Duration of Action
    • Short-Acting Patches
    • Extended-Release Patches
  • By Drug Class
    • NSAID Patches
    • Local Anesthetic Patches
    • Other Medication Patches
  • By Distribution Channel
    • Retail Pharmacies
    • Hospitals and Clinics
  • By Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Key Players
    • Hisamitsu Pharmaceutical Co., Inc.
    • Johnson & Johnson
    • Pfizer Inc.
    • Novartis AG
    • Mylan N.V.
    • Endo Pharmaceuticals
    • Teikoku Pharma USA, Inc.
    • Acorda Therapeutics
    • Ibsa Institut Biochimique SA
    • Alembic Pharmaceuticals
    • Noven Pharmaceuticals, Inc.
    • Teva Pharmaceuticals
    • Strativa Pharmaceuticals
    • Galen Limited
    • Napp Pharmaceuticals

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet , By Type
    • Market Snippet , By Application
    • Market Snippet , By Technology
    • Market Snippet , By Formulation
    • Market Snippet , By Prescription
    • Market Snippet , By Patient Age
    • Market Snippet , By Adhesive Properties
    • Market Snippet , By Duration of Action
    • Market Snippet , By Drug Class
    • Market Snippet , By Distribution Channel
    • Market Snippet , By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Growing demand for effective pain relief and non-invasive treatment
    • Skin Sensitivity and Irritation
    • Emergence of Personalized Pain Management
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Pain Patch Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Pain Patch Market, By Type, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Opioid Pain Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Non-Opioid Pain Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

6. Pain Patch Market, By Application, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Chronic Pain Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Acute Pain Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)

7. Pain Patch Market, By Technology, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Traditional Drug Delivery Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Advanced Drug Delivery Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)

8. Pain Patch Market, By Formulation, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Single Medication Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Combination Therapy Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)

9. Pain Patch Market, By Prescription, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Prescription Pain Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Over-the-Counter (OTC) Pain Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)

10. Pain Patch Market, By Patient Age, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Adult Pain Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Pediatric Pain Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)

11. Pain Patch Market, By Adhesive Properties, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Hypoallergenic Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Standard Adhesive Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)

12. Pain Patch Market, By Duration of Action, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Short-Acting Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Extended-Release Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)

13. Pain Patch Market, By Drug Class, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • NSAID Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Local Anesthetic Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Other Medication Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)

14. Pain Patch Market, By Distribution Channel, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Hospitals and Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)

15. Pain Patch Market, By Region, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Country, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, For Country 2018 -2030
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Prescription, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Patient Age, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Adhesive Properties, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Duration of Action, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Prescription, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Patient Age, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Adhesive Properties, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Duration of Action, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • Central Africa
  • North Africa

16. Competitive Landscape

  • Hisamitsu Pharmaceutical Co., Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Johnson & Johnson
  • Pfizer Inc.
  • Novartis AG
  • Mylan N.V.
  • Endo Pharmaceuticals
  • Teikoku Pharma USA, Inc.
  • Acorda Therapeutics
  • Ibsa Institut Biochimique SA
  • Alembic Pharmaceuticals
  • Noven Pharmaceuticals, Inc.
  • Teva Pharmaceuticals
  • Strativa Pharmaceuticals
  • Galen Limited
  • Napp Pharmaceuticals
  • Analyst Views

17. Section

  • Research Methodology
  • About us